Elizabeth Rich

1.8k citations

56 papers · 1.2k indexed · h-index 17

Impact in

Hematology top 1%
- Hematopoietic Stem Cell Transplantation
- Acute Myeloid Leukemia Research
- Chronic Myeloid Leukemia Treatments
Immunology top 5%
- Immune Cell Function and Interaction
- T-cell and B-cell Immunology

Papers in

Hematology 36
- Acute Myeloid Leukemia Research 21
- Hematopoietic Stem Cell Transplantation 16
- Chronic Myeloid Leukemia Treatments 13
Genetics 15
- Chronic Lymphocytic Leukemia Research 10
- Myeloproliferative Neoplasms: Diagnosis and Treatment 4

Co-authors: Koen van Besien Wendy Stock Andrew Artz Michelle L. Swearingen Richard Meagher Hans Klingemann Han Myint Sally Arai
Journals: Blood (16 papers)Biology of Blood and Marrow Transplantation (11 papers)Journal of Clinical Oncology (4 papers)Bone Marrow Transplantation (3 papers)Journal of Pediatric Gastroenterology and Nutrition (2 papers)
Partner nations: United States Spain France

In The Last Decade

Elizabeth Rich

56 papers receiving 1.2k citations

Peers

Countries citing papers authored by Elizabeth Rich

Since Specialization

Citations

This map shows the geographic impact of Elizabeth Rich's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Elizabeth Rich with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Elizabeth Rich more than expected).

Fields of papers citing papers by Elizabeth Rich

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Elizabeth Rich. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Elizabeth Rich. The network helps show where Elizabeth Rich may publish in the future.

Co-authors

The 25 scholars most cited alongside Elizabeth Rich, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.

Border = papers with Elizabeth Rich Line = papers co-authored together Elizabeth Rich links everyone, so they are left out of the graph.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

#	Work
1	Safety, tolerability, and pharmacokinetics of ASP1235 in relapsed or refractory acute myeloid leukemia: A phase 1 study Leukemia Research ·Monzr M. Al Malki, Mark D. Minden, Elizabeth Rich, Jason E. Hill, Stanley C. Gill, Alan Fan, Christine Fredericks, Amir T. Fathi, Maher Abdul‐Hay	2025	2
2	Gilteritinib in Combination With Induction and Consolidation Chemotherapy and as Maintenance Therapy: A Phase IB Study in Patients With Newly Diagnosed AML Journal of Clinical Oncology ·Keith W. Pratz, Mohamad Cherry, Jessica K. Altman, Brenda Cooper, Nikolai A. Podoltsev, José C. Cruz, Tara L. Lin, Gary J. Schiller, Joseph G. Jurcic, Adam Asch, Ruishan Wu, Jason E. Hill, Stanley C. Gill, Angela James, Elizabeth Rich, Nahla Hasabou, Alexander E. Perl, Mark J. Levis	2023	27
3	PB2319: ZUMA-23: A GLOBAL, PHASE 3, RANDOMIZED CONTROLLED STUDY OF AXICABTAGENE CILOLEUCEL VERSUS STANDARD OF CARE AS FIRST-LINE THERAPY IN PATIENTS WITH HIGH-RISK LARGE B-CELL LYMPHOMA HemaSphere ·Jason R. Westin, Caron A. Jacobson, Julio C. Chávez, Anna Sureda, Franck Morschhauser, Bertram Glaß, Michael Dickinson, Andrew Davies, Ian W. Flinn, David G. Maloney, Martine E.D. Chamuleau, Michael Tees, Allen Xue, Shilpa Shahani, Olga Nikolajeva, Janet Kang, Aida Kaplan, Marco Schupp, Harry Miao, Elizabeth Rich	2023	1
4	Phase 3, Open-Label, Randomized Study of Gilteritinib and Azacitidine Vs Azacitidine for Newly Diagnosed FLT3-Mutated Acute Myeloid Leukemia in Patients Ineligible for Intensive Induction Chemotherapy Blood ·Eunice S. Wang, Pau Montesinos, Mark D. Minden, Je‐Hwan Lee, Michael Heuser, Tomoki Naoe, Wen‐Chien Chou, Kamel Laribi, Jordi Esteve, Jessica K. Altman, Violaine Havelange, Anne-Marie Watson, Elżbieta Patkowska, Shufang Liu, Ruishan Wu, Nisha Philipose, Jason E. Hill, Stanley C. Gill, Elizabeth Rich, Ramón V. Tiu	2021	16
5	A phase III randomized study of gilteritinib versus salvage chemotherapy in FLT3 mutation-positive subjects with relapsed or refractory acute myeloid leukemia Annals of Oncology ·Jie Wang, Jing Li, Adisak Tantiworawit, Shunsuke Izuka, Shunsuke Yamada, Jason E. Hill, Elizabeth Rich, Erkut Bahceci	2018	2
6	Clinical and Safety Profile of High-Dose Interleukin-2 Treatment in Elderly Patients with Metastatic Melanoma and Renal Cell Carcinoma Oncology ·James M. Clark, Benjamin Kelley, Jill Titze, Henry C. Fung, John Maciejewski, Sunita Nathan, Elizabeth Rich, Sanjib Basu, Howard L. Kaufman	2012	11
7	Phase I-II Study of Clofarabine-Melphalan-Alemtuzumab Conditioning for Allogeneic Hematopoietic Cell Transplantation Biology of Blood and Marrow Transplantation ·Koen van Besien, Wendy Stock, Elizabeth Rich, Olatoyosi Odenike, Lucy A. Godley, Peter H. O’Donnell, Justin Kline, Vu Nguyen, Paula del Cerro, Richard A. Larson, Andrew Artz	2011	27
8	Feasibility of clofarabine cytoreduction before allogeneic transplant conditioning for refractory AML Bone Marrow Transplantation ·Frederick L. Locke, Andrew Artz, Elizabeth Rich, Yaowen Zhang, Koen van Besien, Wendy Stock	2010	24
9	Treatment of therapy-related myeloid neoplasms with high-dose cytarabine/mitoxantrone followed by hematopoietic stem cell transplant Leukemia & lymphoma ·Lucy A. Godley, Uchenna O. Njiaju, Margaret Green, Howard Weiner, Lin Shang, Olatoyosi Odenike, Elizabeth Rich, Andrew Artz, Koen van Besien, Christopher K. Daugherty, Yanming Zhang, Michelle M. Le Beau, Wendy Stock, Richard A. Larson	2010	16
10	BK Virus Infection Is Associated with Hematuria and Renal Impairment in Recipients of Allogeneic Hematopoetic Stem Cell Transplants Biology of Blood and Marrow Transplantation ·Peter H. O’Donnell, Kate Swanson, Michelle A. Josephson, Andrew Artz, Sandeep Parsad, Charulata Ramaprasad, Kenneth Pursell, Elizabeth Rich, Wendy Stock, Koen van Besien	2009	64
11	Patterns and kinetics of T-cell chimerism after allo transplant with alemtuzumab-based conditioning: mixed chimerism protects from GVHD, but does not portend disease recurrence Leukemia & lymphoma ·Koen van Besien, Alexander Dew, Lin Shang, Loren Joseph, Lucy A. Godley, Richard A. Larson, Toyosi Odenike, Elizabeth Rich, Wendy Stock, Amittha Wickrema, Andrew Artz	2009	46
12	Infusion of the allogeneic cell line NK-92 in patients with advanced renal cell cancer or melanoma: a phase I trial Cytotherapy ·Sally Arai, Richard Meagher, Michelle L. Swearingen, Han Myint, Elizabeth Rich, Jeff Martinson, Hans Klingemann	2008	333
13	Granulocyte Colony-Stimulating Factor-Based Stem Cell Mobilization in Patients with Sickle Cell Disease Biology of Blood and Marrow Transplantation ·Cara A. Rosenbaum, David Peace, Elizabeth Rich, Koen van Besien	2008	15
14	Successful autologous stem cell collection in patients with chronic myeloid leukemia in complete cytogenetic response, with quantitative measurement of BCR-ABL expression in blood, marrow, and apheresis products Leukemia & lymphoma ·Melinda K. Gordon, Dorie Sher, Theodore Karrison, Partow Kebriaei, Karen Chuang, Yanming Zhang, Diane McDonnell, Andrew Artz, Lucy A. Godley, Olatoyosi Odenike, Elizabeth Rich, Laura C. Michaelis, Michael J. Thirman, Amittha Wickrema, Koen van Besien, Richard A. Larson, Wendy Stock	2008	6
15	Outcomes of patients with AML and MDS who relapse or progress after reduced intensity allogeneic hematopoietic cell transplantation Bone Marrow Transplantation ·Daniel A. Pollyea, Andrew Artz, Wendy Stock, C. K. Daugherty, Lucy A. Godley, Olatoyosi Odenike, Elizabeth Rich, Sonali M. Smith, Todd M. Zimmerman, Yaowen Zhang, Dezheng Huo, Richard A. Larson, Koen van Besien	2007	60
16	The Role of Cooperative Groups in Cancer Clinical Trials Cancer treatment and research ·Ann M. Mauer, Elizabeth Rich, Richard L. Schilsky	2007	7
17	Pre-transplant ganciclovir and post transplant high-dose valacyclovir reduce CMV infections after alemtuzumab-based conditioning Bone Marrow Transplantation ·Justin Kline, Daniel A. Pollyea, Wendy Stock, Andrew Artz, Elizabeth Rich, Lucy A. Godley, Todd M. Zimmerman, Kim D. Thompson, Kenneth Pursell, Richard A. Larson, Koen van Besien	2006	38
18	The incidence of hyperglycemia in hematopoietic stem cell transplant recipients receiving total parenteral nutrition: A pilot study Journal of the American Dietetic Association ·Patricia Sheean, Carol Braunschweig, Elizabeth Rich	2004	37
19	Small intestinal inflammation stimulates abnormal colonic motor activity Gastroenterology ·Miguel Saps, Kenneth L. Cox, Elizabeth Rich, Mike Fitzsimmons, William E. Berquist	1995	1
20	Treatment of Recurrent Pancreatitis by Endoscopic Drainage of a Duodenal Duplication Journal of Pediatric Gastroenterology and Nutrition ·Thomas Lang, William Berquist, Elizabeth Rich, Kristen Cox, P. De Vries, John L. Cahill, E. Baker, Robert G. Gish	1994	6

About Elizabeth Rich

Elizabeth Rich is a scholar working on Hematology, Genetics, Transplantation, Oncology and Immunology, having authored 56 papers that have together received 1.2k indexed citations. Recurring topics across this work include Acute Myeloid Leukemia Research (21 papers), Hematopoietic Stem Cell Transplantation (16 papers), Chronic Myeloid Leukemia Treatments (13 papers), Acute Lymphoblastic Leukemia research (11 papers), Chronic Lymphocytic Leukemia Research (10 papers), Polyomavirus and related diseases (8 papers), CAR-T cell therapy research (5 papers) and Myeloproliferative Neoplasms: Diagnosis and Treatment (4 papers). The work is most often cited by research in Hematology (681 citations), Immunology (451 citations), Oncology (556 citations), Genetics (196 citations) and Transplantation (45 citations). Elizabeth Rich has collaborated with scholars based in United States, Spain and France. Frequent co-authors include Koen van Besien, Wendy Stock, Andrew Artz, Michelle L. Swearingen, Richard Meagher, Hans Klingemann, Han Myint, Sally Arai, Jeff Martinson and Richard A. Larson. Their work appears in journals such as Blood, Biology of Blood and Marrow Transplantation, Journal of Clinical Oncology, Bone Marrow Transplantation and Journal of Pediatric Gastroenterology and Nutrition.

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact